← Back to Search

Micronutrient

Micronutrient for Autism

Phase 2
Waitlist Available
Led By Robert Hendren, DO
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to week 8
Awards & highlights

Study Summary

This trial will investigate whether micronutrients can improve ASD symptoms in children, as well as changes in metabolites.

Eligible Conditions
  • Autism
  • Autism Spectrum Disorder

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to week 8
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to week 8 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in the Autism Behavior Inventory, Short Form (ABI-S)
Change in the Social Responsiveness Scale (SRS)

Trial Design

1Treatment groups
Experimental Treatment
Group I: MicronutrientExperimental Treatment1 Intervention
In this open-label trial, all subjects will receive the daily dose of micronutrient, in the form of one lightning stick per day, which contains 2.9 grams of micronutrients per stick. It will be delivered in a powder form taken sublingually.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Micronutrient
2022
Completed Phase 2
~170

Find a Location

Who is running the clinical trial?

University of California, San FranciscoLead Sponsor
2,506 Previous Clinical Trials
15,238,539 Total Patients Enrolled
Robert Hendren, DOPrincipal InvestigatorUniversity of California, San Francisco
4 Previous Clinical Trials
634 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does ingesting Micronutrient pose any health risks to individuals?

"There is some evidence that Micronutrient produces a safe result, so it has been assigned an indicative score of 2. Unfortunately, no data currently exists to demonstrate efficacy."

Answered by AI

Is participation in this research open to those under 55 years of age?

"The qualifications for this trial specify that prospective participants are between 5 and 22 years old. Altogether, there are 212 trials available to minors and 41 studies available to seniors."

Answered by AI

What criteria must be met for one to be eligible for enrollment in this trial?

"This clinical trial is targeting 20 individuals, aged 5 to 22 years old, who have been clinically diagnosed with Autism Spectrum Disorder. Selected participants must be male or female and enrolled at OHS; additionally, consent from the legal guardian of each participant needs to be obtained in writing as well as confirmation that they are able to comply with all study requirements. The diagnosis will need to adhere to DSM-IV criteria and medical records must be reviewed by an experienced clinician for corroboration."

Answered by AI

Is enrollment for this trial available at the present time?

"Clinicaltrials.gov indicates that the registration period for this trial has been closed since October 4th 2022, however there are presently 252 other trials actively seeking new patients."

Answered by AI

Who else is applying?

What state do they live in?
New York
Pennsylvania
How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Did not meet criteria
~7 spots leftby Apr 2025